POD1UM-303/InterAACT 2: A phase III, global, randomized, double-blind study of retifanlimab or placebo plus carboplatin–paclitaxel in patients with locally advanced or metastatic squamous cell anal carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
POD1UM-303/InterAACT 2: A phase III, global, randomized, double-blind study of retifanlimab or placebo plus carboplatin–paclitaxel in patients with locally advanced or metastatic squamous cell anal carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-24
DOI
10.3389/fonc.2022.935383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival with Cemiplimab in Recurrent Cervical Cancer
- (2022) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study
- (2022) Aurelien Marabelle et al. Lancet Gastroenterology & Hepatology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
- (2021) Nicoletta Colombo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study
- (2021) Sara Lonardi et al. Journal for ImmunoTherapy of Cancer
- International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
- (2020) Sheela Rao et al. JOURNAL OF CLINICAL ONCOLOGY
- LBA42 POD1UM-202: Phase II study of retifanlimab in patients (pts) with squamous carcinoma of the anal canal (SCAC) who progressed following platinum-based chemotherapy
- (2020) S. Rao et al. ANNALS OF ONCOLOGY
- Cancer of the anal region
- (2019) Francesca Valvo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015
- (2019) Ashish A Deshmukh et al. JNCI-Journal of the National Cancer Institute
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- Experimental and investigational drugs for the treatment of anal cancer
- (2018) Alexandre A. Jacome et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
- (2018) Journal for ImmunoTherapy of Cancer
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- 32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part Two
- (2017) Journal for ImmunoTherapy of Cancer
- International trends in anal cancer incidence rates
- (2016) Farhad Islami et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal
- (2015) V. K. Morris et al. ONCOLOGIST
- Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
- (2012) Leonard L. Gunderson et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now